Aclaris Therapeutics, Inc.
$6.54
+0.23 (+3.57%)
Price as of Aug 25, 2026 market close
Performance
- 1 Month
- +21.7%
- 3 Months
- +44.9%
- YTD
- +117.1%
- 1 Year
- +263.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 96.8%
- Largest decline max drawdown, since Aug 2025
- -36.6%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.74
Own ACRS?
See how ACRS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.